Suggestions
Paul van der Horst
Chief Business Officer at AgomAb Therapeutics
Professional Background
Paul van der Horst has established a remarkable career in the biopharmaceutical industry, marked by a series of impactful leadership roles that showcase his expertise in corporate development, business strategy, and investment analysis. Currently, Paul serves as the Chief Business Officer at AgomAb Therapeutics, a position he has held since 2021. In this role, he is responsible for spearheading the company's business initiatives and forging strategic partnerships that enhance AgomAb's mission in the biopharmaceutical sector.
Prior to joining AgomAb, Paul made significant contributions at Galapagos, a publicly traded company on both the Amsterdam Exchange and NASDAQ. During his tenure at Galapagos, he held various critical positions, leading the Corporate Development department, which played a crucial role in shaping the company's growth trajectory and strategic direction. Paul's efforts in investor relations and business development were instrumental in strengthening Galapagos's position within the industry.
Before his impactful role at Galapagos, Paul honed his analytical skills and industry insight while working at Kempen & Co, a boutique investment bank located in Amsterdam. There, he was responsible for brokering European pharmaceutical and biotech stocks to institutional investors across Europe and the United States. His experience in equipping investors with crucial insights paved the way for enhanced investments in innovative treatments and therapies within the biotech landscape.
Education and Achievements
Paul's educational background is a testament to his commitment to academia and ongoing personal development. He holds a Doctor of Philosophy (PhD) degree in Gynaecological Oncology from the highly regarded Erasmus University Medical Center in Rotterdam, The Netherlands. His extensive research in oncology has equipped him with a deep understanding of medical science and the complexities involved in the development of therapeutic solutions.
Beyond his PhD, Paul has pursued diverse educational paths to widen his expertise. He attended Nyenrode Business University, where he studied Financial Management for non-financials, enhancing his acumen for the business aspects of healthcare and investment. Additionally, Paul studied Jazz Drums at Codarts, University for the Arts, showcasing his creative side and ability to thrive within a structured artistic environment.
In terms of accomplishments, Paul has served as a Non-Executive Board Member for several organizations, including Immunetune and Fibrocor Therapeutics, where he provided his expertise in guiding strategic decisions and fostering growth within these entities. Furthermore, he held an advisory position with the Research & Education advisory committee at VVD, contributing valuable insights to improve research initiatives further.
Personal Interests
Outside of his professional commitments, Paul van der Horst is also passionate about philanthropy, angel investments, and funding for research and innovation. His commitment to advancing scientific knowledge and improving healthcare solutions is evident through his active involvement in initiatives that support breakthroughs in research and development.
When he is not engaged in his professional endeavors, Paul enjoys a range of personal interests that reflect his love for adventure and the arts. He is an avid sailor, enjoying the tranquility and challenge of open water. Golf and skiing are also among his favorite pastimes, allowing him to stay active and enjoy the beauty of nature. Furthermore, his love for reading underscores his continual quest for knowledge and learning, continually enriching his life both personally and professionally.
